Horizon Pharma Rheumatology LLC clinical trials
Acquired by Amgen, Oct 6, 2023 · source ↗
The registry lists 1 studies whose lead sponsor is Horizon Pharma Rheumatology LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 11, 2019.
Before and after it joined Amgen
- First submitted before Horizon Pharma Rheumatology LLC became part of Amgen
- 1
- First submitted after Horizon Pharma Rheumatology LLC became part of Amgen
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Horizon Pharma Rheumatology LLC1 study
Something wrong with this grouping? Tell us on the Amgen page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Amgen studies →
- Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic GoutCompletedNCT01466166
Sponsor listed in the registry: Horizon Pharma Rheumatology LLC · First submitted before Horizon Pharma Rheumatology LLC became part of Amgen